Vigmed Holding publ AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Vigmed Holding publishes FY 2014 and long-term financial objectives
Vigmed Holding publ AB:Resolves to publish financial objectives as the company enters into a commercialization phase.Expects to reach net revenue of 5-10 million Swedish crowns with a negative result and cash-flow for FY 2014.Aims to deliver net revenue of 400-600 million Swedish crowns in FY 2018 with a margin level of Earnings before Tax (EBT) of 13-17 percent.Says the more traditional measurement of EBIT is somewhat less relevant for Vigmed considering its chosen business model of controlled outsourcing of manufacturing and distribution.
Latest Developments for Vigmed Holding publ AB
- Vigmed Holding publ AB has been granted a patent for closed system IV catheters
- Vigmed Holding publ issues restatement of year-end 2013 report
- Vigmed Holding publ AB Receives CE-Marking and ISO-Certificate for IV-Cannulae through MBH-International A/S
- NASDAQ OMX Announces First Day of Trading of Vigmed Holding publ AB's Shares on First North
- Share this
- Digg this